Outdoor versus indoor exercise to reduce negative symptoms in schizoaffective disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–55 with schizoaffective disorder and persistent negative symptoms are enrolled to participate in an 8-week supervised physical activity program delivered either outdoors in green spaces or indoors. Participants are regularly followed in the psychiatry department and must be medically cleared for exercise. Negative symptoms are measured using self-report scales (SNS) alongside assessments of quality of life and physical fitness before and after the intervention. The trial compares the effect of exercising in a green environment versus an indoor setting on the intensity of negative symptoms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with schizophrenia, aged 18 to 55 years
* Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
* Regularly monitored in the psychiatry department.
* Have no medical contraindications to physical activity
* Subject affiliated with or entitled to a social security system.
* Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
* Male or female.

Exclusion Criteria:

* Patient unsuitable for study in the opinion of the investigator
* Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
* Any subject presenting chronic or central neurological pathologies.
* Any subject deprived of liberty or subject to legal protection
* Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
* Pregnant women.
* Subject unable to understand the purpose and conditions of the study, unable to give consent.

Where it's running

• CHU de Saint-Etienne
  Saint-Etienne, France, France Recruiting

Study contacts

• Principal investigator: Medhi HOUSNI, Md — CHU de Saint-Etienne
• Study coordinator: Medhi HOUSNI, Md
• Email: Mehdi.Housni@chu-st-etienne.fr
• Phone: (0)477127885

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

  This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.

  Recruiting Ciusss de L'Est de l'Île de Montréal · Montreal, Quebec · NCT07902518

• Can seven tasks help distinguish schizophrenia and schizoaffective disorder from healthy people

  The study tests seven cognitive tasks to see if they can tell apart people with schizophrenia or schizoaffective disorder from healthy adults and predict symptoms like hallucinations and delusions.

  Recruiting at 5 sites Washington University School of Medicine · Irvine, California and 4 other locations · NCT07853807

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

• Brain-derived miRNA biomarkers in first-episode psychosis

  Researchers will test whether specific brain-derived microRNAs in blood can help identify schizophrenia early and track treatment in people with first-episode psychosis on aripiprazole or risperidone.

  Recruiting Northwell Health · Glen Oaks, New York · NCT07703670

• Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders

  This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07395206

• Cognitive Strategies in Early Psychosis 2 – how brain games and pills test decision making

  This study tests whether a single dose of modafinil or d-serine, compared with placebo, changes decision making in people aged 18–35 who have recently begun experiencing psychosis.

  Recruiting Phase 3 University of Minnesota · Minneapolis, Minnesota · NCT07263022

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.